Overview

Efficacy and Safety of Levosimendan in Severe Acute Heart Failure in Critical Children

Status:
Terminated
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of levosimendan versus conventional intensified inotropic treatment, in critical children with severe acute heart failure which persists despite of having received conventional inotropic treatment.
Phase:
Phase 2
Details
Lead Sponsor:
Jose Luis Vazquez Martinez
Treatments:
Simendan